These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32742497)

  • 1. Expression of key regulatory genes in necroptosis and its effect on the prognosis in non-small cell lung cancer.
    Park JE; Lee JH; Lee SY; Hong MJ; Choi JE; Park S; Jeong JY; Lee EB; Choi SH; Lee YH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Park JY
    J Cancer; 2020; 11(18):5503-5510. PubMed ID: 32742497
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulated necroptosis-pathway-associated genes are unfavorable prognostic markers in low-grade glioma and glioblastoma multiforme.
    Dong Y; Sun Y; Huang Y; Dwarakanath B; Kong L; Lu JJ
    Transl Cancer Res; 2019 Jun; 8(3):821-827. PubMed ID: 35116820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in key necroptosis regulators predict prognosis of non-small cell lung cancer after surgical resection.
    Lee JH; Park JE; Hong MJ; Choi JE; Kang HG; Do SK; Lee S; Jeong JY; Shin KM; Do YW; Lee EB; Lee WK; Oh IJ; Kim YC; Choi SH; Lee YH; Seo H; Lee J; Cha SI; Kim CH; Yoo SS; Lee SY; Park JY
    Thorac Cancer; 2023 Sep; 14(26):2678-2686. PubMed ID: 37519036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin ameliorates necroptosis in Glucocorticoid-induced osteonecrosis of the femoral head via RIPK1/RIPK3/MLKL pathway based on network pharmacology analysis.
    Xu X; Fan X; Wu X; Xia R; Liang J; Gao F; Shu J; Yang M; Sun W
    Biochem Biophys Res Commun; 2023 Jun; 661():108-118. PubMed ID: 37099894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
    Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death.
    Chen S; Lv X; Hu B; Shao Z; Wang B; Ma K; Lin H; Cui M
    Apoptosis; 2017 May; 22(5):626-638. PubMed ID: 28289909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke via Inhibition of RIPK1-Mediated RIPK3/MLKL Signaling.
    Deng XX; Li SS; Sun FY
    Aging Dis; 2019 Aug; 10(4):807-817. PubMed ID: 31440386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necroptosis-driving genes
    Nicolè L; Sanavia T; Cappellesso R; Maffeis V; Akiba J; Kawahara A; Naito Y; Radu CM; Simioni P; Serafin D; Cortese G; Guido M; Zanus G; Yano H; Fassina A
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35264437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing necroptosis by scavenging ROS production alleviates heat stress-induced intestinal injury.
    Li L; Tan H; Zou Z; Gong J; Zhou J; Peng N; Su L; Maegele M; Cai D; Gu Z
    Int J Hyperthermia; 2020; 37(1):517-530. PubMed ID: 32423248
    [No Abstract]   [Full Text] [Related]  

  • 11. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRADD Mediates RIPK1-Independent Necroptosis Induced by Tumor Necrosis Factor.
    Wang L; Chang X; Feng J; Yu J; Chen G
    Front Cell Dev Biol; 2019; 7():393. PubMed ID: 32039207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Trend of ripk1/ripk3 and mlkl Mediated Necroptosis Pathway in Patients with Different Stages of Prostate Cancer as Promising Progression Biomarkers.
    Heidaryan F; Bamehr H; Babaabasi B; Emamvirdizadeh A; Mohammadzadeh N; Khalili A
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.
    Xu Y; Gao H; Hu Y; Fang Y; Qi C; Huang J; Cai X; Wu H; Ding X; Zhang Z
    Exp Cell Res; 2019 Sep; 382(2):111463. PubMed ID: 31247189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24(S)-Hydroxycholesterol induces RIPK1-dependent but MLKL-independent cell death in the absence of caspase-8.
    Vo DK; Urano Y; Takabe W; Saito Y; Noguchi N
    Steroids; 2015 Jul; 99(Pt B):230-7. PubMed ID: 25697054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive enhancing effects of pazopanib in D‑galactose/ovariectomized Alzheimer's rat model: insights into the role of RIPK1/RIPK3/MLKL necroptosis signaling pathway.
    Abdelhady R; Younis NS; Ali O; Shehata S; Sayed RH; Nadeem RI
    Inflammopharmacology; 2023 Oct; 31(5):2719-2729. PubMed ID: 37458952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
    Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
    Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma levels of RIPK1, RIPK3, and MLKL in patients with coronary atherosclerotic heart disease and its clinical predictive value.
    Xiao Z; Zhang Y; Kuang Y; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1096-1103. PubMed ID: 33051424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-325-3p protects the heart after myocardial infarction by inhibiting RIPK3 and programmed necrosis in mice.
    Zhang DY; Wang BJ; Ma M; Yu K; Zhang Q; Zhang XW
    BMC Mol Biol; 2019 Jun; 20(1):17. PubMed ID: 31248365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.